[
    {
        "dcterms:creator": [],
        "dcterms:description": "The dataset consists of fluorescent images that were generated to assess the ability of regulatory-approved or in late-stage clinical trials compounds to modulate the in vitro infection from SARS-CoV-2 in both VERO and HRCE cell lines.",
        "dcterms:title": "RxRx19a",
        "dcterms:issued": "2021",
        "dcterms:language": "",
        "dcterms:identifier": "",
        "dcat:theme": [
            "Biological Imaging",
            "COVID-19 Drug Discovery"
        ],
        "dcat:keyword": [
            "Fluorescent images",
            "SARS-CoV-2",
            "Drug screening",
            "Cell viability"
        ],
        "dcat:landingPage": "https://www.rxrx.ai/rxrx19",
        "dcterms:hasVersion": "",
        "dcterms:format": "Image",
        "mls:task": [
            "Classification",
            "Dose-response modeling",
            "Zero-shot learning"
        ]
    },
    {
        "dcterms:creator": [],
        "dcterms:description": "A dataset consisting of 296 GB of 16-bit fluorescent microscopy images, created under controlled conditions to provide the appropriate data for discerning biological variation in the common context of changing experimental conditions.",
        "dcterms:title": "RxRx1",
        "dcterms:issued": "2021",
        "dcterms:language": "",
        "dcterms:identifier": "",
        "dcat:theme": [
            "Biological Imaging",
            "Drug Discovery"
        ],
        "dcat:keyword": [
            "Fluorescent microscopy",
            "Biological variation",
            "Experimental conditions"
        ],
        "dcat:landingPage": "https://www.rxrx.ai/rxrx1",
        "dcterms:hasVersion": "",
        "dcterms:format": "Image",
        "mls:task": [
            "Classification"
        ]
    }
]